Peter Lynch fit · Growth at a reasonable price (GARP)
Is iRadimed Corporation (IRMD) a Peter Lynch Stock?
Strong GARP candidate — growth at a reasonable price.
85/100
ALikely Lynch stock
5/6 criteria passed
Peter Lynch's Criteria, Applied to IRMD
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key77.5%
Revenue CAGR ≥ 10%
26.0%
Net margin > 0
26.3%
How IRMD Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.32B
P/E (TTM)
67.4x
ROIC (TTM)
19.34%
Gross margin
77.07%
Frequently Asked Questions
What is IRMD's Peter Lynch fit score?
IRMD scores 85/100 on our Peter Lynch fit engine — grade A. Strong GARP candidate — growth at a reasonable price.
Does Peter Lynch actually own IRMD?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends IRMD.
How often is this score updated?
IRMD's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends IRMD.